Atalanta Therapeutics is a biotechnology company pioneering new treatment options for neurodegenerative diseases by utilizing its proprietary RNA interference platform. Learn more at www.atalantatx.com.
Location: United States, Massachusetts, Boston
Total raised: $110M
Investors 1
| Date | Name | Website |
| - | F-Prime Ca... | fprimecapi... |
Funding Rounds 1
| Date | Series | Amount | Investors |
| 13.01.2021 | Series A | $110M | F-Prime Ca... |
Mentions in press and media 4
| Date | Title | Description | Source |
| 12.01.2021 | Daily funding roundup - January 11th, 2021 | Aulos Bioscience has raised $40M; Komodo Health landed $44M; EQRx secured $500M Hello Ralphie: Hell... | vator.tv/n... |
| 11.01.2021 | Atalanta Therapeutics Raises $110M in Series A Funding | Atalanta Therapeutics, a Boston, MA-based biotechnology company pioneering new treatment options for... | finsmes.co... |
| 11.01.2021 | Atalanta Therapeutics Raises $110M in Series A Funding | Atalanta Therapeutics, a Boston, MA-based biotechnology company pioneering new treatment options for... | citybizlis... |
| 11.01.2021 | Atalanta Therapeutics Raises $110M in Series A Funding | Atalanta Therapeutics, a Boston, MA-based biotechnology company pioneering new treatment options for... | archive.ci... |